Abstract:
Despite the adoption and use of different infection
prevention and control measures, the coronavirus
disease (COVID-19) pandemic keeps surging on with
globally increasing morbidities and mortalities. The
lack of a specific therapeutic intervention against
COVID-19 warrants the use of non-conventional
potent alternatives. In recent times, probiotics have
shown to mitigate numerous health challenges,
including animal and human infectious diseases
through competitive exclusion or antagonism of
pathogens, modulation of host-microbiota,
secretion of antimicrobial compounds and
stimulation of immune responses. The presentation of COVID-19 as severe respiratory distress leading
to gastrointestinal tract involvement could be
mitigated through probiotics administration which
beneficially modulates the microbiota and immune
responses with an attendant reduction in
morbidities, hence curtailing the COVID-19
pandemic.
